e-learning
resources
Paris 2018
Sunday, 16.09.2018
New pharmacological strategies in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Insulin potentiates methacholine and serotonin-induced increases in tracheal smooth muscle intracellular calcium
B. Proskocil (Portland, United States of America), D. Jacoby (Portland , United States of America), A. Fryer (Portland, United States of America), Z. Nie (Portland, United States of America)
Source:
International Congress 2018 – New pharmacological strategies in airway diseases
Session:
New pharmacological strategies in airway diseases
Session type:
Oral Presentation
Number:
518
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Proskocil (Portland, United States of America), D. Jacoby (Portland , United States of America), A. Fryer (Portland, United States of America), Z. Nie (Portland, United States of America). Late Breaking Abstract - Insulin potentiates methacholine and serotonin-induced increases in tracheal smooth muscle intracellular calcium. 518
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM)
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015
TGF-beta alters TRPC6 expression and calcium handling via smad2/3 in human airway smooth muscle
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Late Breaking Abstract - Blockade of ß2-adrenoceptor augments anaphylaxis-induced increase in pulmonary vascular permeability in anesthetized mice
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Estrogen requires the NO-cGMP-PKG pathway in order to prevent the hyper-responsiveness of asthmatic tracheal smooth muscle to carbachol
Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina
Year: 2005
The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Raised airway CO2 relaxes bronchial smooth muscle and diminishes methacholine induced bronchoconstriction
Source: Eur Respir J 2001; 18: Suppl. 33, 253s
Year: 2001
Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease?
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Airway smooth muscle contractility is increased following coculture with fibrocytes
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Beneficial effects of menthol are mediated via a TRPM8-independent mechanism
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015
Mevastatin ameliorates sphingosine 1-phosphate-induced inflammation in human tracheal smooth muscle cells
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Ionic mechanisms and Ca2+ handling in airway smooth muscle
Source: Eur Respir J 2007; 30: 114-133
Year: 2007
Ryanodine receptors decant internal Ca2+ store in human and bovine airway smooth muscle
Source: Eur Respir J 2008; 32: 275-284
Year: 2008
Hypoxia exerts dualistic effects on inflammatory and proliferative responses of healthy and asthmatic primary human bronchial smooth muscle cells
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Regulation of actin dynamics by WNT-5A: Implications for human airway smooth muscle contraction
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
IL33 and TNFalpha synergistically enhance store operated Ca
2+
entry in cultured human airway smooth muscle cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept